FDA NDC Directory · JSON-LD · Markdown

Enoxaparin Sodium

NDC 70710-1763 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076726
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS SUBCUTANEOUS
Active ingredientsENOXAPARIN SODIUM (150 mg/mL)
Marketing started20210401
Package count1

External sources

Source: openFDA. Public-domain (CC0).